GOLDBACH, PIERRE,MAHLER, HANNS-CHRISTIAN,MUELLER, ROBERT
申请号：
CA2860543
公开号：
CA2860543C
申请日:
2013.03.05
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical formulation comprising about 50 mg/ml 200 mg/ml of an Abeta antibody, about 0.01 % 0.1% poloxamer, about 5 mM 50 mM of a buffer, about 100 m M 300 m M of a stabilizer at a pH of about 4.5 7Ø
